LDR | |
01293nam a2200313 a 4500 |
001 |
|
002606172 |
003 |
|
MiAaHDL |
005 |
|
20241229000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
930323s1992 nyua b 001 0 eng d |
020 |
⊔ |
⊔ |
‡a0471588369
‡q(Wiley-Liss)
|
020 |
⊔ |
⊔ |
‡z18810630033
‡q(APH)
|
035 |
⊔ |
⊔ |
‡a(MiU)990026061720106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990026061720106381
|
035 |
⊔ |
⊔ |
‡z(MiU)MIU01000000000000002606172-goog
|
035 |
⊔ |
⊔ |
‡a(OCoLC)26134185
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph002606172
|
040 |
⊔ |
⊔ |
‡aWSM
‡cWSM
‡dTMV
‡dEYM
‡dUtOrBLW
|
096 |
⊔ |
⊔ |
‡aQU 68 O615a 1992
|
100 |
1 |
⊔ |
‡aOpie, Lionel H.
|
245 |
1 |
0 |
‡aAngiotensin-converting enzyme inhibitors :
‡bscientific basis for clinical use /
‡cLionel H. Opie.
|
260 |
⊔ |
⊔ |
‡aNew York :
‡bWiley-Liss :
‡bAuthor's Pub. House,
‡c1992.
|
300 |
⊔ |
⊔ |
‡axi, 266 p. :
‡bill. ; 26 x 12 cm
|
336 |
⊔ |
⊔ |
‡atext
‡btxt
‡2rdacontent
|
337 |
⊔ |
⊔ |
‡aunmediated
‡bn
‡2rdamedia
|
338 |
⊔ |
⊔ |
‡avolume
‡bnc
‡2rdacarrier
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references and index.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aAngiotensin-Converting Enzyme Inhibitors.
‡0http://id.nlm.nih.gov/mesh/D000806
|
650 |
⊔ |
0 |
‡aHypotensive agents.
‡0http://id.loc.gov/authorities/subjects/sh85063821
|
650 |
⊔ |
0 |
‡aAngiotensin converting enzyme
‡xInhibitors.
‡0http://id.loc.gov/authorities/subjects/sh85005040
|
899 |
⊔ |
⊔ |
‡a39015025175624
|
CID |
⊔ |
⊔ |
‡a002606172
|
DAT |
0 |
⊔ |
‡a20241218053404.0
‡b20241229000000.0
|
DAT |
1 |
⊔ |
‡a20250103134342.0
‡b2025-01-04T11:21:08Z
|
DAT |
2 |
⊔ |
‡a2023-06-21T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡cmiu
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990026061720106381
‡aMiU
‡bSDR
‡cMIU
‡f002606172
‡pmdp.39015025175624
‡sMIU
‡1990026061720106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20250104
‡sgoogle
‡umdp.39015025175624
‡y1992
‡ric
‡qbib
‡tUS bib date1 >= 1930
|